Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Å. Helland · SciRah

Researcher profile · Semantic Scholar

Å. Helland

Share profile

Å. Helland — researcher profile on SciRah

h-index: 50
Works: 270
Citations: 11K

Most-cited papers

Rovalpituzumab Tesirine as a Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer: Results From the Phase 3 MERU Study.
M. Johnson, Z. Zvirbule, K. Laktionov, Å. Helland +18 more
2021Journal of Thoracic Oncology123 citations Open access
Semantic Scholar
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms
J. Lehtiö, T. Arslan, Ioannis Siavelis, Yan-Bo Pan +25 more
2021Nature Cancer100 citations Open access
Semantic Scholar
The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
A. Frafjord, L. Buer, C. Hammarström, H. Aamodt +5 more
2021Frontiers in Immunology71 citations Open access
Semantic Scholar
Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study).
I. J. Eide, Å. Helland, S. Ekman, A. Mellemgaard +5 more
2020Lung Cancer67 citations Open access
Semantic Scholar
The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery
Å. Öjlert, A. Halvorsen, D. Nebdal, M. Lund-Iversen +4 more
2019Molecular Oncology65 citations Open access
Semantic Scholar
Abstract
M. Larsen, M. Lopez-Perez, E. Dickson, P. Ampomah +22 more
2021Scandinavian Journal of Immunology58 citations
Semantic Scholar
COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
T. Johannesen, S. Smeland, S. Aaserud, E. Buanes +3 more
2021Frontiers in Oncology50 citations Open access
Semantic Scholar
Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
E. Grøvik, Darvin Yi, Michael Iv, E. Tong +8 more
2021npj Digital Medicine46 citations Open access
Semantic Scholar
Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects
Ruyang Zhang, Chao Chen, Xuesi Dong, S. Shen +26 more
2020Chest38 citations Open access
Semantic Scholar
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer
J. Wolf, Å. Helland, I. Oh, M. Migliorino +11 more
2022ESMO Open37 citations Open access
Semantic Scholar
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
Ruyang Zhang, Linjing Lai, Jie-Yu He, Chao Chen +20 more
2019Epigenetics36 citations Open access
Semantic Scholar
2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data
J. Ottesen, Darvin Yi, E. Tong, Michael Iv +9 more
2023Frontiers in Neuroinformatics35 citations Open access
Semantic Scholar
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
Å. Helland, H. Russnes, G. L. Fagereng, K. Al-Shibli +48 more
2022Journal of Translational Medicine32 citations Open access
Semantic Scholar
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial.
M. Rakaee, S. Andersen, K. Giannikou, E. Paulsen +21 more
2023Annals of Oncology29 citations Open access
Semantic Scholar
A national precision cancer medicine implementation initiative for Norway
K. Taskén, H. Russnes, E. Aas, L. Bjørge +18 more
2022Nature Medicine25 citations
Semantic Scholar
Serum RNAs can predict lung cancer up to 10 years prior to diagnosis
S. Umu, H. Langseth, V. Zuber, Å. Helland +2 more
2022eLife24 citations Open access
Semantic Scholar
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
V. Haakensen, A. Nowak, E. Ellingsen, S. Farooqi +6 more
2021Journal of Translational Medicine24 citations Open access
Semantic Scholar
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis
Ruyang Zhang, Linjing Lai, Xuesi Dong, Jie-Yu He +23 more
2019Molecular Oncology23 citations Open access
Semantic Scholar
Antibody combinations for optimized staining of macrophages in human lung tumours
A. Frafjord, Renate Skarshaug, C. Hammarström, B. Stanković +7 more
2020Scandinavian Journal of Immunology22 citations Open access
Semantic Scholar
Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer.
S. Popat, O. Brustugun, J. Cadranel, E. Felip +8 more
2021Lung Cancer20 citations Open access
Semantic Scholar
Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials
I. J. Eide, S. Stensgaard, Å. Helland, S. Ekman +7 more
2021Translational Lung Cancer Research20 citations Open access
Semantic Scholar
Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
A. Abravan, H. Eide, Å. Helland, E. Malinen
2020Clinical and Translational Radiation Oncology19 citations Open access
Semantic Scholar
Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial
H. Horndalsveen, T. Alver, A. M. Dalsgaard, L. Rogg +8 more
2022Molecular Oncology18 citations Open access
Semantic Scholar
A 10‐year prediagnostic follow‐up study shows that serum RNA signals are highly dynamic in lung carcinogenesis
S. Umu, H. Langseth, A. Keller, E. Meese +3 more
2019Molecular Oncology17 citations Open access
Semantic Scholar
Age-related treatment patterns for stage I NSCLC in three European countries.
R. Damhuis, S. Senan, A. Khakwani, S. Harden +2 more
2021Journal of Geriatric Oncology16 citations
Semantic Scholar
Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
J. Berg, C. Ramberg, Jon Olav Haugstvedt, M. Bengtson +4 more
2021Frontiers in Oncology16 citations Open access
Semantic Scholar
Epigenetic–smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early‐stage NSCLC patients
Xinyu Ji, Lijuan Lin, S. Shen, Xuesi Dong +25 more
2020Molecular Oncology16 citations Open access
Semantic Scholar
Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor
Å. Öjlert, D. Nebdal, I. Snapkov, V. Olsen +4 more
2021Molecular Oncology15 citations Open access
Semantic Scholar
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
Xuesi Dong, Ruyang Zhang, Jie-Yu He, Linjing Lai +22 more
2019Aging15 citations Open access
Semantic Scholar
Increase in curative treatment and survival of lung cancer in Norway 2001–2016
S. Solberg, Y. Nilssen, O. Brustugun, T. Grimsrud +11 more
2019European Journal of Epidemiology15 citations Open access
Semantic Scholar
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
Stefanie H. Müller, A. Lai, M. Valkovskaya, K. Michailidou +203 more
2023Genome Medicine14 citations Open access
Semantic Scholar
Concordance between clinical and pathology TNM-staging in lung cancer.
S. Solberg, Y. Nilssen, Odd Terje Brustugun, Per Magnus Haram +5 more
2022Lung Cancer14 citations Open access
Semantic Scholar
Epigenome-wide gene–age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients
Chao Chen, Yong-Yue Wei, Liangmin Wei, Jiajin Chen +23 more
2020Aging14 citations Open access
Semantic Scholar
Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
S. Farooqi, Zhi Zhao, Å. Öjlert, S. Thunold +6 more
2024Frontiers in Immunology13 citations Open access
Semantic Scholar
Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people
Y. Nilssen, S. Solberg, O. Brustugun, B. Møller +3 more
2023European Journal of Cardio-Thoracic Surgery13 citations Open access
Semantic Scholar
Distribution and characteristics of malignant tumours by lung lobe
Y. Nilssen, O. Brustugun, L. Fjellbirkeland, Å. Helland +3 more
2024BMC Pulmonary Medicine12 citations Open access
Semantic Scholar
Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
T. Huynh, H. Aass, R. Falk, G. Astrup +10 more
2022Journal of cancer survivorship11 citations Open access
Semantic Scholar
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
A. Khadse, V. Haakensen, L. Silwal-Pandit, J. Hamfjord +6 more
2022Frontiers in Oncology10 citations Open access
Semantic Scholar
Epigenome‐wide three‐way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early‐stage NSCLC
Xinyu Ji, Lijuan Lin, Juan-Juan Fan, Yi Li +13 more
2021Molecular Oncology10 citations Open access
Semantic Scholar
Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer – predictors of response and impact of previous radiotherapy
Å. Öjlert, D. Nebdal, M. Lund-Iversen, Renée Åstrøm Ellefsen +4 more
2020Acta oncologica10 citations Open access
Semantic Scholar
Sex differences in burden of adverse events in patients receiving immunotherapy.
R. Miceli, H. Eriksson, A. Eustace, Giuseppe Lo Russo +15 more
2023Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI
I. Digernes, L. Nilsen, E. Grøvik, A. Bjørnerud +8 more
2020Physics in Medicine and Biology9 citations Open access
Semantic Scholar
The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases
B. Stanković, H. Aamodt, Heidi Anine Korsmo Bjørhovde, Elisabeth Müller +5 more
2020Scandinavian Journal of Immunology9 citations Open access
Semantic Scholar
OA02.07 Phase 3 ALUR Study of Alectinib in Pretreated ALK+ NSCLC: Final Efficacy, Safety and Targeted Genomic Sequencing Analyses
J. Wolf, Å. Helland, I. Oh, M. Migliorino +10 more
2019Journal of Thoracic Oncology9 citations Open access
Semantic Scholar
Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
L. Silwal-Pandit, S. M. Stålberg, H. Johansson, G. Mermelekas +10 more
2022Cancer Research Communications8 citations Open access
Semantic Scholar
Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors
M. Bjaanæs, Gro Nilsen, A. Halvorsen, H. Russnes +5 more
2021BMC Cancer8 citations Open access
Semantic Scholar
Two truncating variants in FANCC and breast cancer risk
T. Dörk, P. Peterlongo, A. Mannermaa, M. Bolla +199 more
2019Scientific Reports8 citations Open access
Semantic Scholar
Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients – a nationwide and longitudinal study
Johanne Elise Nyen, Anja Ødegård Booth, Ø. Husby, Christoffer Bugge +6 more
2025Frontiers in Oncology7 citations Open access
Semantic Scholar
Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway
Siri Børø, S. Thoresen, Å. Helland
2022Frontiers in Oncology7 citations Open access
Semantic Scholar
OA01.07 A Phase II Study of the Oral Selective AXL Inhibitor Bemcentinib with Pembrolizumab in Patients with Advanced NSCLC
M. Krebs, Å. Helland, E. C. Costa, E. A. Aperribay +17 more
20217 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

O. Brustugun×17
Invite
O. Brustugun — researcher profile on SciRah
M. Bjaanæs×11
Invite
M. Bjaanæs — researcher profile on SciRah
Anna Karlsson×8
Invite
Anna Karlsson — researcher profile on SciRah
M. Planck×8
Invite
M. Planck — researcher profile on SciRah

×8

Invite

J. Staaf — researcher profile on SciRah

Ruyang Zhang×7

Invite

Ruyang Zhang — researcher profile on SciRah

Invite

S. Shen — researcher profile on SciRah

Invite

Lijuan Lin — researcher profile on SciRah

Invite

L. Su — researcher profile on SciRah

Andrea Shafer×7

Invite

Andrea Shafer — researcher profile on SciRah

Invite

M. Esteller — researcher profile on SciRah

Yong-Yue Wei×7

Invite

Yong-Yue Wei — researcher profile on SciRah